Results 261 to 270 of about 57,164 (280)

Investigating outcomes and treatment of long coronavirus disease 2019 in patients with multiple sclerosis treated with rituximab: A case series study. [PDF]

J Res Med Sci
Shirani K, Khorvash F, Karamshahi A, Maghamimehr A.   +3 more
europepmc   +1 more source

Construction and validation of a cell based reporter assay for identifying inhibitors of SARS coronavirus 2 RNA dependent RNA polymerase activity. [PDF]

Sci Rep
Kang E, Yoon H, Lee J, Lee J, Kim S, Jo I, Han SB, Jeong DG, Cho S.   +8 more
europepmc   +1 more source

COVID-19 management in patients with comorbid conditions. [PDF]

World J Virol
Sanyaolu A, Okorie C, Marinkovic A, Prakash S, Balendra V, Lehachi A, Abbasi AF, Haider N, Abioye A, Orish VN, Antonio A, Badaru O, Pandit R, Izurieta R.   +13 more
europepmc   +1 more source

Synthetic host defense peptide inhibits SARS-CoV-2 replication <i>in vitro</i>. [PDF]

Antimicrob Agents Chemother
Harfoot R, Lawley B, Hernández LC, Kuang J, Hills FR, Sinha S, Allais MJM, Bird TW, Hird CP, Taylor JA, Bostina M, Comoletti D, Haney EF, Hancock REW, Pletzer D, Quiñones-Mateu ME.   +15 more
europepmc   +1 more source

Remdesivir associated with reduced mortality in hospitalized COVID-19 patients: treatment effectiveness using real-world data and natural language processing. [PDF]

BMC Infect Dis
Arribas López JR, Ruiz Seco MP, Fanjul F, Díaz Pollán B, González Ruano Pérez P, Ferre Beltrán A, De Miguel Buckley R, Portillo Horcajada L, De Álvaro Pérez C, Barroso Santos Carvalho PJ, Savana Research Group, Riera Jaume M.   +11 more
europepmc   +1 more source

Pharmacokinetics of SARS-CoV-2 RNA Polymerase Inhibitor Remdesivir in Participants With Moderate and Severe Hepatic Impairment. [PDF]

Clin Transl Sci
Regan S, Humeniuk R, Caro L, Abdelghany M, Davies S, Baysa A, Shen G, Hyland RH, Kim A.   +8 more
europepmc   +1 more source

Clinical outcomes of early remdesivir administration in hospitalized patients at high risk for severe COVID-19 during the Omicron wave. [PDF]

BMC Infect Dis
La YJ, Oh WS, Kim C, Lim MN, Jeon YD.
europepmc   +1 more source

The impact of remdesivir on SARS-CoV-2 evolution in vivo. [PDF]

JCI Insight
Ling-Hu T, Simons LM, Rios-Guzman E, Carvalho AM, Agnes MFR, Alisoltanidehkordi A, Ozer EA, Lorenzo-Redondo R, Hultquist JF.   +8 more
europepmc   +1 more source

Lower Mortality Risk Associated With Remdesivir + Dexamethasone Versus Dexamethasone Alone for the Treatment of Patients Hospitalized for COVID-19. [PDF]

Clin Infect Dis
Mozaffari E, Chandak A, Gottlieb RL, Chima-Melton C, Berry M, Oppelt T, Okulicz JF, Amin AN, Welte T, Sax PE, Kalil AC.   +10 more
europepmc   +1 more source

Case report: Persistent COVID-19 in a patient with B cell lymphoma refractory to antiviral treatment due to resistance to Remdesivir. [PDF]

IDCases
de Assumpção LECC, Romeo BGP, Guerra JCC, Camargo LFA, Nagaoka MA, Amgarten DE, Dorlass EG, Petroni RC, Cardoso ACA, Ruiz RM, Bittante CD, Teich VD, Pinho JRR, Doi AM.   +13 more
europepmc   +1 more source